Ram. why do a larger follow up ?
This study will be criticized for being small ( around 2,000 ) and lacking in diversity ( few black or latino veterans ...and almost exclusively male ) .
Theres no P value for the data . Wether thats needed in RWE analysis I'll defer to Laurents opinion ...but the P value gives you an idea if the results were by chance ...eg P value of .05 means the data has a 1 in 20 risk of being by chance.
The more larger studies you have confirming risk reduction or benefit the better .
Look at the number of trials / studies for Statins ( around 20 ) , PSCK9's ...at least 3 large randomized , international independent trials . SGLT2 inhibitors and now GLP-1 drugs .
Chk the conclusion of the study Laurent linked . The lead investigator recommends larger follow ups to better define benefit .
Kiwi
News 
Market Data 
Discover 
